{"version":"1.0","type":"link","title":"Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.","author_name":"Junttila MR 외","author_url":"https://prs-insight.online/author/Junttila%20MR","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97594","thumbnail_width":1200,"thumbnail_height":630}